|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
6098800 |
| 003 |
ICU |
| 005 |
20080103113700.0 |
| 008 |
060623s2006 dcua b 001 0 eng |
| 010 |
|
|
|a 2006021123
|
| 020 |
|
|
|a 1555813739
|
| 020 |
|
|
|a 9781555813734
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d NhCcYBP
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC311
|b .D362 2006
|
| 060 |
1 |
0 |
|a WF 300
|b D188p 2006
|
| 082 |
0 |
0 |
|a 616.9/9507
|2 22
|
| 100 |
1 |
|
|a Dannenberg, Arthur M.
|0 http://id.loc.gov/authorities/names/n2006182673
|1 http://viaf.org/viaf/24038002
|
| 245 |
1 |
0 |
|a Pathogenesis of human pulmonary tuberculosis :
|b insights from the rabbit model /
|c Arthur M. Dannenberg.
|
| 260 |
|
|
|a Washington, D.C. :
|b ASM Press,
|c c2006.
|
| 300 |
|
|
|a xiv, 453 p. :
|b ill. ;
|c 27 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Introduction /
|r Max B. Lurie and Arthur M. Dannenberg, Jr. --
|g Section 1.
|t Pathogenesis of Tuberculosis --
|g 1.
|t Overview: Childhood and adult tuberculosis, bacillary virulence, host resistance, contagion, and prevention --
|g 2.
|t Stages in the Pathogenesis of Human and Rabbit Tuberculosis --
|g 3.
|t Types of Human Pulmonary Tuberculosis --
|g 4.
|t Liquefaction of Caseous Foci and Cavity Formation --
|g Section 2.
|t Immunology of Tuberculosis --
|g 5.
|t Delayed-Type Hypersensitivity, Cell-Mediated Immunity, and Antibodies in Tuberculosis: Their local and systemic natures; innate immunity --
|g 6.
|t Macrophages and Other Cells in Tuberculous Lesions: Including dendritic cells and lymphocytes --
|g Section 3.
|t Tuberculous Lesions --
|g 7.
|t Structural Components of Tuberculous Lesions --
|g 8.
|t Microvascular Density in Tuberculous Lesions: In developing and healing BCG lesions and in tuberculin reactions --
|g 9.
|t Early Pulmonary Lesions in Rabbits: Produced by an intravenous injection of tubercle bacilli --
|g 10.
|t Macrophage Turnover, Division, and Activation in Tuberculous Lesions: In developing, peak, and "healed" BCG lesions --
|g 11.
|t Lurie's Pulmonary Tubercle-Count Method: To assess bacillary virulence, genetic resistance of the host, and vaccine efficacy --
|g Section 4.
|t Tuberculosis in Rabbits and other Common Laboratory Animals --
|g 12.
|t Natural Airborne Infection: Resistance to the establishment of tuberculosis and to its progress --
|g 13.
|t Response of Rabbits to Inhaled Tubercle Bacilli Including BCG: Response to inhaled bovine- and human-type tubercle bacilli and to inhaled BCG --
|g 14.
|t Characteristics of Resistance and Susceptibility to Tuberculosis in Lurie's Inbred Rabbits --
|g 15.
|t Comparisons of Tuberculosis in Rabbits, Mice, and Guinea Pigs --
|g Section 5.
|t Effects of Hormones and X-Irradiation on Tuberculosis --
|g 16.
|t Effects of Cortisone and Adrenocorticotropic Hormone on Tuberculosis --
|g 17.
|t Effects of Estrogen, Chorionic Gonadotropin, and Thyroid Hormones on Tuberculosis --
|g 18.
|t Effects of Whole-Body X-Irradiation on Tuberculosis --
|g Section 6.
|t Cytokines and Vascular Adhesion Molecules in Tuberculous Lesions --
|g 19.
|t Cytokine Production in Primary BCG Lesions: Nonspecific and antigen-specific cytokine production in developing and healing primary BCG lesions --
|g 20.
|t Cytokine Production in Reinfection BCG Lesions and in Tuberculin Reactions: Effects of immunization on cell composition and cytokines --
|g 21.
|t Vascular Adhesion Molecules in Tuberculous Lesions: ICAM-1, VCAM-1, and ELAM-1 in developing and healing rabbit dermal BCG lesions --
|g Section 7.
|t Tuberculosis Vaccines --
|g 22.
|t Principles and Guidelines for Developing Better Tuberculosis Vaccines --
|g 23.
|t Characteristics of Rabbit BCG Lesions and Efficacies of BCG and Mycobacterium microti Vaccines --
|g Section 8.
|t Past, Present, and Future --
|g 24.
|t Summary and Conclusions --
|g 25.
|t Suggested Future Research and Unanswered Questions: Research on the host; research on the bacillus; vaccines and immunotherapy; development of new drugs --
|g A.
|t Award of the Trudeau Medal for 1955: The Trudeau Medal of the National Tuberculosis Association for 1955 awarded to Max B. Lurie --
|g B.
|t Obituary of Max B. Lurie, M.D. (1893-1966) /
|r Esmond R. Long, M.D., Ph.D., Sc.D. --
|g C.
|t Publications of Max B. Lurie --
|g D.
|t Publications of Arthur M. Dannenberg, Jr. --
|g E.
|t Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 (Table of Contents): Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Georgia --
|g F.
|t Collected Abstracts of Chapters in This Volume --
|g G.
|t Acknowledgments.
|
| 600 |
1 |
0 |
|a Lurie, Max B.
|q (Max Bernard),
|d 1893-1966.
|0 http://id.loc.gov/authorities/names/no2003084646
|1 http://viaf.org/viaf/66164584
|
| 650 |
|
0 |
|a Tuberculosis
|x Animal models.
|0 http://id.loc.gov/authorities/subjects/sh2009002679
|
| 650 |
|
0 |
|a Tuberculosis
|x Pathophysiology.
|
| 650 |
1 |
2 |
|a Tuberculosis, Pulmonary
|x physiopathology.
|
| 650 |
2 |
2 |
|a Models, Animal.
|
| 650 |
2 |
2 |
|a Mycobacterium bovis
|x pathogenicity.
|
| 650 |
2 |
2 |
|a Rabbits.
|
| 650 |
2 |
2 |
|a Tuberculosis, Pulmonary
|x microbiology.
|
| 650 |
|
7 |
|a Tuberculosis
|x Animal models.
|2 fast
|0 http://id.worldcat.org/fast/fst01158500
|
| 710 |
2 |
|
|a American Society for Microbiology.
|0 http://id.loc.gov/authorities/names/n79005678
|1 http://viaf.org/viaf/128399176
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)70218048
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 6556bd3b-5ac2-5097-b02c-f2530545699c
|s 4c21eea3-023c-5555-b437-2f1821981bd7
|
| 928 |
|
|
|t Library of Congress classification
|a RC311 .D362 2006
|l ASR
|c ASR-SciASR
|i 5264888
|
| 927 |
|
|
|t Library of Congress classification
|a RC311 .D362 2006
|l ASR
|c ASR-SciASR
|e BELL
|e CRERAR
|b 75362822
|i 8060047
|
